Vor Biopharma Financial Overview
Vor Biopharma's market cap is currently $271.91M. The company's EPS TTM is $-121.63; its P/E ratio is -0.04; Vor Biopharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.64. See an overview of income statement, balance sheet, and cash flow financials.
